Trial Profile

Does adding YF476 to amoxicillin and clarithromycin aid eradication of H. pylori from healthy carriers?

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 Jul 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Netazepide (Primary) ; Amoxicillin; Clarithromycin
Indications Helicobacter pylori infections
Focus Therapeutic Use
Sponsors Trio Medicines

Most Recent Events

27 Jul 2020 Status changed from suspended to completed.
17 Mar 2012 Planned end date changed from 28 Mar 2008 to 28 Jan 2008 as reported by EudraCT.
17 Mar 2012 Actual initiation date changed from 28 Sep 2007 to 13 Jul 2007 as reported by EudraCT.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com